Search Results 141-150 of 17239 for hba1c

1. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   HbA1c >=48 millimoles per mole (mmol/mol) (>=6.5%) at screening. Bone fracture within 6 months prior to screening, or presence of a known unresolved or ...

2. A Randomized Trial Evaluating Control-IQ Technology In Adults With Type 2 Diabetes (2IQP) - Mayo Clinic

   Presence of a hemoglobinopathy or other condition that is expected to affect the measurement of HbA1c. Pregnant (positive urine hCG), breast feeding, plan ...

3. DAYBREAK: Phase 2 Study In Patients With Specific Gene Defects In The MC4R Pathway - Mayo Clinic

   Glycated hemoglobin (HbA1C) >10.0% at Screening. History of significant liver disease other than non-alcoholic fatty liver disease (NAFLD) or nonalcoholic ...

4. Randomized Global Phase 3 Study to Evaluate the Impact of Obeticholic Acid Treatment on Nonalcoholic Steatohepatitis Patients - Mayo Clinic

   HbA1c > 9.5%. Total bilirubin > 1.5 mg/dL. Evidence of other known forms of known chronic liver disease such as alcoholic liver disease, hepatitis B ...

5. Differences in Blood Cell Types in Peripheral Arterial Disease and Healthy Subjects - Mayo Clinic

   Poorly controlled diabetes (HbA1c > 8%). BMI < 18 or > 35. Recent other major surgery or illness within 30 days. Use of immunosuppresive medications or ...

6. Islet GLP-1 in Prediabetes - Clinical Trials

   HbA1c ³ 6.5%; Use of any glucose-lowering agents including metformin or sulfonylureas. For female subjects: positive pregnancy test at the time of enrollment ...

7. A Study Assessing The Effectiveness And Safety Of Alpelisib + Nab-paclitaxel In Subjects With Advanced Triple Negative Breast Cancer - Mayo Clinic

   Subject with an established diagnosis of diabetes mellitus type I or uncontrolled type II based on Fasting Plasma Glucose and HbA1c. Subject has impairment ...

8. Late-night eating: OK if you have diabetes? - Mayo Clinic

   Late-night snacks may be OK with diabetes. Make healthy choices to keep from having high blood sugar in the morning.

9. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

   HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. History of T1DM or any other type than type 2 (e.g. endocrinopathy, genetic ...

10. A Study Of Simvastatin Therapy For Moderate And Severe COPD - Mayo Clinic

    Elevated HbA1c > 6.5%. It is at the discretion of the Principal Investigator if the potential participant will not be a reliable study subject to complete ...